Two Binding Sites for [3H]PBR28 in Human Brain: Implications for TSPO PET Imaging of Neuroinflammation
[11C]PBR28, a radioligand targeting the translocator protein (TSPO), does not produce a specific binding signal in approximately 14% of healthy volunteers. This phenomenon has not been reported for [11C]PK11195, another TSPO radioligand. We measured the specific binding signals with [3H]PK11195 and...
Saved in:
Published in | Journal of cerebral blood flow and metabolism Vol. 30; no. 9; pp. 1608 - 1618 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London, England
SAGE Publications
01.09.2010
Nature Publishing Group Sage Publications Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | [11C]PBR28, a radioligand targeting the translocator protein (TSPO), does not produce a specific binding signal in approximately 14% of healthy volunteers. This phenomenon has not been reported for [11C]PK11195, another TSPO radioligand. We measured the specific binding signals with [3H]PK11195 and [3H]PBR28 in brain tissue from 22 donors. Overall, 23% of the samples did not generate a visually detectable specific autoradiographic signal with [3H]PBR28, although all samples showed [3H]PK11195 binding. There was a marked reduction in the affinity of [3H]PBR28 for TSPO in samples with no visible [3H]PBR28 autoradiographic signal (Ki=188±15.6 nmol/L), relative to those showing normal signal (Ki=3.4±0.5 nmol/L, P<0.001). Of this latter group, [3H]PBR28 bound with a two-site fit in 40% of cases, with affinities (Ki) of 4.0±2.4 nmol/L (high-affinity site) and 313±77 nmol/L (low-affinity site). There was no difference in Kd or Bmax for [3H]PK11195 in samples showing no [3H]PBR28 autoradiographic signal relative to those showing normal [3H]PBR28 autoradiographic signal. [3H]PK11195 bound with a single site for all samples. The existence of three different binding patterns with PBR28 (high-affinity binding (46%), low-affinity binding (23%), and two-site binding (31%)) suggests that a reduction in [11C]PBR28 binding may not be interpreted simply as a reduction in TSPO density. The functional significance of differences in binding characteristics warrants further investigation. |
---|---|
AbstractList | [(11)C]PBR28, a radioligand targeting the translocator protein (TSPO), does not produce a specific binding signal in approximately 14% of healthy volunteers. This phenomenon has not been reported for [(11)C]PK11195, another TSPO radioligand. We measured the specific binding signals with [(3)H]PK11195 and [(3)H]PBR28 in brain tissue from 22 donors. Overall, 23% of the samples did not generate a visually detectable specific autoradiographic signal with [(3)H]PBR28, although all samples showed [(3)H]PK11195 binding. There was a marked reduction in the affinity of [(3)H]PBR28 for TSPO in samples with no visible [(3)H]PBR28 autoradiographic signal (K(i)=188+/-15.6 nmol/L), relative to those showing normal signal (K(i)=3.4+/-0.5 nmol/L, P<0.001). Of this latter group, [(3)H]PBR28 bound with a two-site fit in 40% of cases, with affinities (K(i)) of 4.0+/-2.4 nmol/L (high-affinity site) and 313+/-77 nmol/L (low-affinity site). There was no difference in K(d) or B(max) for [(3)H]PK11195 in samples showing no [(3)H]PBR28 autoradiographic signal relative to those showing normal [(3)H]PBR28 autoradiographic signal. [(3)H]PK11195 bound with a single site for all samples. The existence of three different binding patterns with PBR28 (high-affinity binding (46%), low-affinity binding (23%), and two-site binding (31%)) suggests that a reduction in [(11)C]PBR28 binding may not be interpreted simply as a reduction in TSPO density. The functional significance of differences in binding characteristics warrants further investigation. [ super(11)C]PBR28, a radioligand targeting the translocator protein (TSPO), does not produce a specific binding signal in approximately 14% of healthy volunteers. This phenomenon has not been reported for [ super(11)C]PK11195, another TSPO radioligand. We measured the specific binding signals with [ super(3)H]PK11195 and [ super(3)H]PBR28 in brain tissue from 22 donors. Overall, 23% of the samples did not generate a visually detectable specific autoradiographic signal with [ super(3)H]PBR28, although all samples showed [ super(3)H]PK11195 binding. There was a marked reduction in the affinity of [ super(3)H]PBR28 for TSPO in samples with no visible [ super(3)H]PBR28 autoradiographic signal (K sub(i)=188 plus or minus 15.6nmol/L), relative to those showing normal signal (K sub(i)=3.4 plus or minus 0.5nmol/L, P<0.001). Of this latter group, [ super(3)H]PBR28 bound with a two-site fit in 40% of cases, with affinities (K sub(i)) of 4.0 plus or minus 2.4nmol/L (high-affinity site) and 313 plus or minus 77nmol/L (low-affinity site). There was no difference in K sub(d) or B sub(max) for [ super(3)H]PK11195 in samples showing no [ super(3)H]PBR28 autoradiographic signal relative to those showing normal [ super(3)H]PBR28 autoradiographic signal. [ super(3)H]PK11195 bound with a single site for all samples. The existence of three different binding patterns with PBR28 (high-affinity binding (46%), low-affinity binding (23%), and two-site binding (31%)) suggests that a reduction in [ super(11)C]PBR28 binding may not be interpreted simply as a reduction in TSPO density. The functional significance of differences in binding characteristics warrants further investigation. [11C]PBR28, a radioligand targeting the translocator protein (TSPO), does not produce a specific binding signal in approximately 14% of healthy volunteers. This phenomenon has not been reported for [11C]PK11195, another TSPO radioligand. We measured the specific binding signals with [3H]PK11195 and [3H]PBR28 in brain tissue from 22 donors. Overall, 23% of the samples did not generate a visually detectable specific autoradiographic signal with [3H]PBR28, although all samples showed [3H]PK11195 binding. There was a marked reduction in the affinity of [3H]PBR28 for TSPO in samples with no visible [3H]PBR28 autoradiographic signal (Ki=188±15.6 nmol/L), relative to those showing normal signal (Ki=3.4±0.5 nmol/L, P<0.001). Of this latter group, [3H]PBR28 bound with a two-site fit in 40% of cases, with affinities (Ki) of 4.0±2.4 nmol/L (high-affinity site) and 313±77 nmol/L (low-affinity site). There was no difference in Kd or Bmax for [3H]PK11195 in samples showing no [3H]PBR28 autoradiographic signal relative to those showing normal [3H]PBR28 autoradiographic signal. [3H]PK11195 bound with a single site for all samples. The existence of three different binding patterns with PBR28 (high-affinity binding (46%), low-affinity binding (23%), and two-site binding (31%)) suggests that a reduction in [11C]PBR28 binding may not be interpreted simply as a reduction in TSPO density. The functional significance of differences in binding characteristics warrants further investigation. [ 11 C]PBR28, a radioligand targeting the translocator protein (TSPO), does not produce a specific binding signal in approximately 14% of healthy volunteers. This phenomenon has not been reported for [ 11 C]PK11195, another TSPO radioligand. We measured the specific binding signals with [ 3 H]PK11195 and [ 3 H]PBR28 in brain tissue from 22 donors. Overall, 23% of the samples did not generate a visually detectable specific autoradiographic signal with [ 3 H]PBR28, although all samples showed [ 3 H]PK11195 binding. There was a marked reduction in the affinity of [ 3 H]PBR28 for TSPO in samples with no visible [ 3 H]PBR28 autoradiographic signal ( K i =188±15.6 nmol/L), relative to those showing normal signal ( K i =3.4±0.5 nmol/L, P <0.001). Of this latter group, [ 3 H]PBR28 bound with a two-site fit in 40% of cases, with affinities ( K i ) of 4.0±2.4 nmol/L (high-affinity site) and 313±77 nmol/L (low-affinity site). There was no difference in K d or B max for [ 3 H]PK11195 in samples showing no [ 3 H]PBR28 autoradiographic signal relative to those showing normal [ 3 H]PBR28 autoradiographic signal. [ 3 H]PK11195 bound with a single site for all samples. The existence of three different binding patterns with PBR28 (high-affinity binding (46%), low-affinity binding (23%), and two-site binding (31%)) suggests that a reduction in [ 11 C]PBR28 binding may not be interpreted simply as a reduction in TSPO density. The functional significance of differences in binding characteristics warrants further investigation. [ 11 C]PBR28, a radioligand targeting the translocator protein (TSPO), does not produce a specific binding signal in approximately 14% of healthy volunteers. This phenomenon has not been reported for [ 11 C]PK11195, another TSPO radioligand. We measured the specific binding signals with [ 3 H]PK11195 and [ 3 H]PBR28 in brain tissue from 22 donors. Overall, 23% of the samples did not generate a visually detectable specific autoradiographic signal with [ 3 H]PBR28, although all samples showed [ 3 H]PK11195 binding. There was a marked reduction in the affinity of [ 3 H]PBR28 for TSPO in samples with no visible [ 3 H]PBR28 autoradiographic signal ( K i =188±15.6 nmol/L), relative to those showing normal signal ( K i =3.4±0.5 nmol/L, P<0.001). Of this latter group, [ 3 H]PBR28 bound with a two-site fit in 40% of cases, with affinities ( K i ) of 4.0±2.4 nmol/L (high-affinity site) and 313±77 nmol/L (low-affinity site). There was no difference in K d or B max for [ 3 H]PK11195 in samples showing no [ 3 H]PBR28 autoradiographic signal relative to those showing normal [ 3 H]PBR28 autoradiographic signal. [ 3 H]PK11195 bound with a single site for all samples. The existence of three different binding patterns with PBR28 (high-affinity binding (46%), low-affinity binding (23%), and two-site binding (31%)) suggests that a reduction in [ 11 C]PBR28 binding may not be interpreted simply as a reduction in TSPO density. The functional significance of differences in binding characteristics warrants further investigation. |
Author | Rabiner, Eugenii A Matthews, Paul M Owen, David R Gunn, Roger N Parker, Christine A Tang, Sac-Pham Bergstrom, Mats Reynolds, Richard Bennacef, Idriss Wilkins, Martin R Wells, Lisa A Howell, Owain W |
Author_xml | – sequence: 1 givenname: David R surname: Owen fullname: Owen, David R email: d.owen@imperial.ac.uk – sequence: 2 givenname: Owain W surname: Howell fullname: Howell, Owain W – sequence: 3 givenname: Sac-Pham surname: Tang fullname: Tang, Sac-Pham – sequence: 4 givenname: Lisa A surname: Wells fullname: Wells, Lisa A – sequence: 5 givenname: Idriss surname: Bennacef fullname: Bennacef, Idriss – sequence: 6 givenname: Mats surname: Bergstrom fullname: Bergstrom, Mats – sequence: 7 givenname: Roger N surname: Gunn fullname: Gunn, Roger N – sequence: 8 givenname: Eugenii A surname: Rabiner fullname: Rabiner, Eugenii A – sequence: 9 givenname: Martin R surname: Wilkins fullname: Wilkins, Martin R – sequence: 10 givenname: Richard surname: Reynolds fullname: Reynolds, Richard – sequence: 11 givenname: Paul M surname: Matthews fullname: Matthews, Paul M – sequence: 12 givenname: Christine A surname: Parker fullname: Parker, Christine A |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23293111$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/20424634$$D View this record in MEDLINE/PubMed |
BookMark | eNp1ku1rFDEQxoNU7LX60a-yCCIIW_O22V0_CF6pXqHYw54giITZbHLm2E3OZLfF_97cS60W_ZIQ5jfPzDOZI3TgvNMIPSX4hGBWvV6pxvQnFKe3YA_QhBRFnZeYiAM0wbQkuSirL4foKMYVxrhiRfEIHVLMKReMT5BZ3Phsal1r3TK7soOOmfEh-8pm3-bTT7TKrMtmYw8umwaw7k123q87q2Cw3u3QxdX8MpufLVIElhsVb7KPegzeOtNB32_Rx-ihgS7qJ_v7GH1-f7Y4neUXlx_OT99d5IqXfMhbApgzkk5TAyWMl9QUhGtNeV1hRUXDsSCg24oI3bRlC8liUbcaGkEV0ewYvd3prsem163SbgjQyXWwPYSf0oOVf0ec_S6X_lrSmtdU4CTwci8Q_I9Rx0H2NirddeC0H6NM1RgRlJBEPr9HrvwYXHInS15zTKuSJ-jZn_38buT2AxLwYg9AVNCZAE7ZeMcxmuptq7Edp4KPMWgjlR22o002bCcJlpt1kNt1kJt1kIKlrPxe1q3w__hXOz7CUt_5-Tf8Czoww5M |
CODEN | JCBMDN |
CitedBy_id | crossref_primary_10_1038_jcbfm_2014_46 crossref_primary_10_1016_j_bmcl_2014_01_080 crossref_primary_10_1111_bcp_15392 crossref_primary_10_1038_jcbfm_2011_55 crossref_primary_10_1007_s12017_016_8385_y crossref_primary_10_1080_13543776_2022_2032649 crossref_primary_10_1007_s11307_015_0877_x crossref_primary_10_1021_acsomega_1c01678 crossref_primary_10_2967_jnumed_116_178996 crossref_primary_10_3390_ijms20133161 crossref_primary_10_1039_c3md00249g crossref_primary_10_1093_brain_awad322 crossref_primary_10_1002_syn_21970 crossref_primary_10_1007_s12149_015_0948_8 crossref_primary_10_1021_acs_jmedchem_1c01562 crossref_primary_10_2967_jnumed_117_203109 crossref_primary_10_1146_annurev_med_041709_133809 crossref_primary_10_1021_acs_molpharmaceut_2c00157 crossref_primary_10_1021_acschemneuro_6b00056 crossref_primary_10_1053_j_semnuclmed_2024_09_007 crossref_primary_10_2967_jnumed_120_243717 crossref_primary_10_1016_j_cct_2023_107087 crossref_primary_10_1007_s00259_011_1864_3 crossref_primary_10_1007_s00259_017_3799_9 crossref_primary_10_1111_ejn_14392 crossref_primary_10_1007_s11307_012_0589_4 crossref_primary_10_3390_molecules26051250 crossref_primary_10_1007_s40336_015_0141_z crossref_primary_10_2967_jnumed_111_091694 crossref_primary_10_1007_s00259_021_05617_4 crossref_primary_10_1111_jnc_14615 crossref_primary_10_1177_0271678X16653615 crossref_primary_10_2967_jnumed_111_094565 crossref_primary_10_1007_s11481_010_9243_6 crossref_primary_10_1007_s00259_010_1622_y crossref_primary_10_1002_ana_25251 crossref_primary_10_1186_ar4509 crossref_primary_10_1038_jcbfm_2012_46 crossref_primary_10_3390_ijms242417419 crossref_primary_10_1016_j_neuroimage_2013_09_021 crossref_primary_10_1042_BCJ20170648 crossref_primary_10_1177_0271678X19858003 crossref_primary_10_1016_j_jalz_2019_02_004 crossref_primary_10_1021_jm5007947 crossref_primary_10_1039_C6MD00523C crossref_primary_10_2967_jnumed_117_195396 crossref_primary_10_3233_JAD_179929 crossref_primary_10_1007_s00249_020_01487_0 crossref_primary_10_12688_f1000research_11603_1 crossref_primary_10_2967_jnumed_110_079459 crossref_primary_10_1109_TRPMS_2018_2871760 crossref_primary_10_1186_s12974_015_0236_5 crossref_primary_10_2967_jnumed_113_135129 crossref_primary_10_3390_molecules27092780 crossref_primary_10_1002_acn3_50837 crossref_primary_10_3390_jcm12010116 crossref_primary_10_3390_life11060484 crossref_primary_10_1007_s12264_017_0202_6 crossref_primary_10_2147_NDT_S334027 crossref_primary_10_2967_jnumed_117_202200 crossref_primary_10_1016_j_cpet_2020_12_003 crossref_primary_10_1021_jm101230g crossref_primary_10_1177_0271678X17710182 crossref_primary_10_1007_s11481_017_9765_2 crossref_primary_10_3390_cells12172128 crossref_primary_10_1021_jm4001874 crossref_primary_10_3390_ijms22020951 crossref_primary_10_1038_jcbfm_2011_147 crossref_primary_10_1161_STROKEAHA_110_598821 crossref_primary_10_1016_j_yexcr_2016_12_005 crossref_primary_10_1093_brain_awv184 crossref_primary_10_1002_syn_21681 crossref_primary_10_1177_0269881112443746 crossref_primary_10_1016_j_ejmech_2015_02_004 crossref_primary_10_1093_brain_awv066 crossref_primary_10_1021_acschemneuro_0c00362 crossref_primary_10_1021_acs_jmedchem_3c01716 crossref_primary_10_2967_jnumed_115_156083 crossref_primary_10_3389_fpsyt_2020_00362 crossref_primary_10_1016_j_ejmech_2018_09_069 crossref_primary_10_1016_j_jfluchem_2011_03_020 crossref_primary_10_1186_s12974_016_0778_1 crossref_primary_10_2967_jnumed_112_118885 crossref_primary_10_1177_1352458510390070 crossref_primary_10_1007_s00259_016_3587_y crossref_primary_10_1212_NXI_0000000000001144 crossref_primary_10_1586_14737175_2014_896201 crossref_primary_10_1016_S2215_0366_20_30255_8 crossref_primary_10_1007_s00259_015_3021_x crossref_primary_10_3389_fnins_2020_00871 crossref_primary_10_1016_j_ejrad_2020_109182 crossref_primary_10_1517_17460441_2015_1032240 crossref_primary_10_3389_fneur_2018_01033 crossref_primary_10_1039_D1MD00035G crossref_primary_10_1021_cn500138n crossref_primary_10_1111_jnc_15615 crossref_primary_10_1007_s11307_019_01323_8 crossref_primary_10_1038_nrd3295 crossref_primary_10_1007_s00259_015_3043_4 crossref_primary_10_1177_0271678X17748786 crossref_primary_10_1186_1742_2094_11_120 crossref_primary_10_1186_s13195_019_0491_2 crossref_primary_10_1176_appi_ajp_2016_16020171 crossref_primary_10_1007_s00259_021_05495_w crossref_primary_10_1016_j_bbamem_2013_12_013 crossref_primary_10_1016_j_neuroimage_2011_10_060 crossref_primary_10_1016_j_bbi_2020_01_020 crossref_primary_10_1093_braincomms_fcac019 crossref_primary_10_2967_jnumed_119_231985 crossref_primary_10_1007_s00259_025_07109_1 crossref_primary_10_3389_fimmu_2019_02724 crossref_primary_10_1038_nrneurol_2017_129 crossref_primary_10_1007_s00259_014_2955_8 crossref_primary_10_1007_s11910_017_0733_2 crossref_primary_10_2967_jnumed_113_121020 crossref_primary_10_1093_brain_awab336 crossref_primary_10_1186_s13550_014_0020_z crossref_primary_10_1016_j_nucmedbio_2019_01_003 crossref_primary_10_1016_j_nbd_2018_06_004 crossref_primary_10_1007_s40336_015_0146_7 crossref_primary_10_2967_jnumed_119_241059 crossref_primary_10_1039_C4OB01933D crossref_primary_10_2967_jnumed_115_165019 crossref_primary_10_1002_stem_2253 crossref_primary_10_1371_journal_pone_0185767 crossref_primary_10_3389_fnins_2022_806876 crossref_primary_10_2174_0929867329666220329204054 crossref_primary_10_1016_j_bbi_2018_09_018 crossref_primary_10_1016_j_seizure_2016_10_023 crossref_primary_10_1002_jlcr_3199 crossref_primary_10_1007_s00702_017_1731_x crossref_primary_10_1007_s13244_011_0128_x crossref_primary_10_1016_j_jalz_2014_08_105 crossref_primary_10_3390_ph16020279 crossref_primary_10_3389_fnimg_2023_1142463 crossref_primary_10_1053_j_semnuclmed_2015_09_001 crossref_primary_10_1007_s00259_019_04462_w crossref_primary_10_1007_s00259_021_05248_9 crossref_primary_10_1038_jcbfm_2012_131 crossref_primary_10_1002_glia_22357 crossref_primary_10_1007_s11910_019_0934_y crossref_primary_10_1097_SHK_0000000000001546 crossref_primary_10_1016_j_neuroimage_2011_12_078 crossref_primary_10_1177_0271678X17699223 crossref_primary_10_1007_s00259_011_2041_4 crossref_primary_10_1002_mds_26907 crossref_primary_10_1007_s00259_018_3974_7 crossref_primary_10_1002_syn_21765 crossref_primary_10_1038_s41596_021_00584_4 crossref_primary_10_3233_JAD_190127 crossref_primary_10_2967_jnumed_110_086629 crossref_primary_10_2214_AJR_18_19822 crossref_primary_10_1016_j_neuroimage_2011_02_020 crossref_primary_10_1038_mp_2015_1 |
Cites_doi | 10.1016/j.nbd.2005.08.002 10.1016/j.neuroimage.2009.11.056 10.1016/j.neuroimage.2007.11.011 10.1016/j.tips.2006.06.005 10.1021/jm0707370 10.1016/0361-9230(87)90033-5 10.1002/syn.20394 10.1021/bi010431+ 10.1016/0006-8993(90)90973-F 10.1210/endo.135.4.7925120 10.1007/s007020070090 10.1111/j.1471-4159.1989.tb07361.x 10.1016/j.nbd.2008.08.001 10.1016/0140-6736(92)90576-O 10.1016/0006-2952(89)90594-7 10.1016/S0014-2999(97)01395-2 10.1097/NEN.0b013e318188b204 10.1111/j.1471-4159.1987.tb01007.x 10.1111/j.1471-4159.1990.tb05794.x 10.1016/j.nucmedbio.2007.12.009 10.1006/bbrc.2001.4975 10.1016/j.bmc.2003.10.050 10.1093/brain/123.11.2321 10.1210/endo.137.12.8940407 10.1023/A:1005933226966 10.1093/brain/124.10.2014 10.1074/jbc.272.44.28102 10.1021/jm7014556 10.1111/j.1600-0773.1988.tb00922.x 10.1016/j.neuroimage.2007.09.063 |
ContentType | Journal Article |
Copyright | 2010 ISCBFM 2015 INIST-CNRS Copyright Nature Publishing Group Sep 2010 Copyright © 2010 International Society for Cerebral Blood Flow & Metabolism, Inc. 2010 International Society for Cerebral Blood Flow & Metabolism, Inc. |
Copyright_xml | – notice: 2010 ISCBFM – notice: 2015 INIST-CNRS – notice: Copyright Nature Publishing Group Sep 2010 – notice: Copyright © 2010 International Society for Cerebral Blood Flow & Metabolism, Inc. 2010 International Society for Cerebral Blood Flow & Metabolism, Inc. |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88A 88E 8AO 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7TK 5PM |
DOI | 10.1038/jcbfm.2010.63 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection (ProQuest) ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection ProQuest Health & Medical Collection Medical Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Neurosciences Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) Neurosciences Abstracts |
DatabaseTitleList | ProQuest Central Student Neurosciences Abstracts CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry |
DocumentTitleAlternate | [3H]PBR28 binding in the human brain |
EISSN | 1559-7016 |
EndPage | 1618 |
ExternalDocumentID | PMC2949260 2127460911 20424634 23293111 10_1038_jcbfm_2010_63 10.1038_jcbfm.2010.63 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Medical Research Council grantid: G0900897 – fundername: Wellcome Trust – fundername: Medical Research Council grantid: G9901399 – fundername: Medical Research Council grantid: G0700356 |
GroupedDBID | --- -Q- -TM .55 .GJ 0R~ 29K 2WC 36B 39C 3O- 4.4 53G 54M 5GY 5RE 5VS 70F 7X7 88E 8AO 8FE 8FH 8FI 8FJ 8R4 8R5 AABMB AACKU AACMV AADUE AAEWN AAGGD AAGMC AAJIQ AAJPV AAKGS AANSI AAPEO AAQGT AAQXH AAQXI AARDL AARIX AATAA AATBZ AAUAS AAVDI AAXOT AAYTG AAZBJ ABAWP ABAWZ ABCCA ABCJG ABDWY ABEIX ABFWQ ABHKI ABJNI ABJZC ABKRH ABLUO ABNCE ABPGX ABPNF ABQKF ABQNX ABQXT ABRHV ABUJY ABUWG ABVFX ABXGC ABYTW ACARO ACDSZ ACDXX ACFEJ ACFMA ACGBL ACGFO ACGFS ACGZU ACJER ACJTF ACLFY ACLHI ACNXM ACOFE ACOXC ACPRK ACROE ACSIQ ACUAV ACUIR ACXKE ACXMB ADBBV ADEBD ADEIA ADMPF ADNON ADRRZ ADTBJ ADUKL ADVBO ADZZY AECGH AENEX AEPTA AEQLS AESZF AEUHG AEWDL AEWHI AEXFG AEXNY AFEET AFFNX AFFZS AFKRA AFKRG AFMOU AFOSN AFQAA AFUIA AFVCE AGHKR AGKLV AGNHF AGPXR AGWFA AHDMH AHMBA AIGRN AJABX AJEFB AJMMQ AJSCY AJUZI AJXAJ AJXGE ALIPV ALKWR ALMA_UNASSIGNED_HOLDINGS AMCVQ ANDLU AOIJS ARTOV AUTPY AYAKG B8M BAWUL BBNVY BBRGL BDDNI BENPR BHPHI BKIIM BKSCU BPACV BPHCQ BSEHC BVXVI BWJAD C45 CAG CBRKF CCPQU CDWPY CFDXU COF CORYS CQQTX CS3 CUTAK D-I DC- DC. DIK DOPDO DV7 E3Z EBS EE. EJD EMOBN F5P FHBDP FYUFA GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION GX1 H13 HCIFZ HMCUK HYE HZ~ J8X JSO K.F KQ8 LK8 M1P M7P O9- OK1 OVD P2P P6G PHGZM PHGZT PQQKQ PROAC PSQYO Q1R Q2X RNS RNTTT ROL RPM SASJQ SAUOL SCNPE SFC SHG SPQ SPV TEORI TR2 UKHRP W2D X7M YFH YOC ZGI ZONMY ZPPRI ZRKOI ZSSAH ZXP AAYXX AJGYC CITATION AAEJI AAPII AJVBE IQODW PJZUB PPXIY PQGLB ALTZF CGR CUY CVF ECM EIF M4V NPM PMFND 3V. 7XB 88A 8FK AJHME AZQEC DWQXO GNUQQ K9. PKEHL PQEST PQUKI PRINS 7TK 5PM |
ID | FETCH-LOGICAL-c474t-d1a04311a0f9a213472f514ee24980c26b4061aed816ebd7da02759deab62c1e3 |
IEDL.DBID | 7X7 |
ISSN | 0271-678X |
IngestDate | Thu Aug 21 18:16:13 EDT 2025 Mon Jul 21 11:03:14 EDT 2025 Wed Aug 13 09:06:39 EDT 2025 Sat May 31 02:08:41 EDT 2025 Mon Jul 21 09:15:45 EDT 2025 Thu Apr 24 23:07:39 EDT 2025 Tue Jul 01 05:27:38 EDT 2025 Tue Jun 17 22:36:26 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | [3H]PBR28 PBR radioligand binding TSPO [3H]PK11195 Human Nervous system diseases H]PBR28 Cerebral disorder Encephalon Central nervous system disease H]PK11195 [ Positron emission tomography Cerebrovascular disease |
Language | English |
License | https://journals.sagepub.com/page/policies/text-and-data-mining-license CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c474t-d1a04311a0f9a213472f514ee24980c26b4061aed816ebd7da02759deab62c1e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
OpenAccessLink | https://journals.sagepub.com/doi/pdf/10.1038/jcbfm.2010.63 |
PMID | 20424634 |
PQID | 749402874 |
PQPubID | 31524 |
PageCount | 11 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2949260 proquest_miscellaneous_759316211 proquest_journals_749402874 pubmed_primary_20424634 pascalfrancis_primary_23293111 crossref_citationtrail_10_1038_jcbfm_2010_63 crossref_primary_10_1038_jcbfm_2010_63 sage_journals_10_1038_jcbfm_2010_63 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2010-09-01 |
PublicationDateYYYYMMDD | 2010-09-01 |
PublicationDate_xml | – month: 09 year: 2010 text: 2010-09-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | London, England |
PublicationPlace_xml | – name: London, England – name: New York, NY – name: United States – name: London |
PublicationTitle | Journal of cerebral blood flow and metabolism |
PublicationTitleAlternate | J Cereb Blood Flow Metab |
PublicationYear | 2010 |
Publisher | SAGE Publications Nature Publishing Group Sage Publications Ltd |
Publisher_xml | – name: SAGE Publications – name: Nature Publishing Group – name: Sage Publications Ltd |
References | Imaizumi, Briard, Zoghbi, Gourley, Hong, Fujimura, Pike, Innis, Fujita 2008; 39 Kreisl, Fujita, Fujimura, Kimura, Jenko, Kannan, Hong, Morse, Zoghbi, Gladding, Jacobson, Oh, Pike, Innis 2010; 49 Banati, Newcombe, Gunn, Cagnin, Turkheimer, Heppner, Price, Wegner, Giovannoni, Miller, Perkin, Smith, Hewson, Bydder, Kreutzberg, Jones, Cuzner, Myers 2000; 123 Boujrad, Vidic, Papadopoulos 1996; 137 Hall, Wedel, Halldin, Kopp, Farde 1990; 55 Joseph-Liauzun, Farges, Delmas, Ferrara, Loison 1997; 272 Gerhard, Pavese, Hotton, Turkheimer, Es, Hammers, Eggert, Oertel, Banati, Brooks 2006; 21 Miyazawa, Hamel, Diksic 1998; 38 Cagnin, Myers, Gunn, Lawrence, Stevens, Kreutzberg, Jones, Banati 2001; 124 Fookes, Pham, Mattner, Greguric, Loc'h, Liu, Berghofer, Shepherd, Gregoire, Katsifis 2008; 51 Boujrad, Gaillard, Garnier, Papadopoulos 1994; 135 Wilson, Garcia, Parkes, McCormick, Stephenson, Houle, Vasdev 2008; 35 Broaddus, Bennett 1990; 518 Doble, Malgouris, Daniel, Daniel, Imbault, Basbaum, Uzan, Gueremy, Le 1987; 18 Awad, Gavish 1987; 49 Rao, Butterworth 1997; 340 Awad, Gavish 1989; 38 Papadopoulos, Baraldi, Guilarte, Knudsen, Lacapere, Lindemann, Norenberg, Nutt, Weizman, Zhang, Gavish 2006; 27 Hall, Wedel, Sallemark 1988; 63 Briard, Zoghbi, Imaizumi, Gourley, Shetty, Hong, Cropley, Fujita, Innis, Pike 2008; 51 Lacapere, Delavoie, Li, Peranzi, Maccario, Papadopoulos, Vidic 2001; 284 Eshleman, Murray 1989; 53 Venneti, Wang, Nguyen, Wiley 2008; 67 Edison, Archer, Gerhard, Hinz, Pavese, Turkheimer, Hammers, Tai, Fox, Kennedy, Rossor, Brooks 2008; 32 Fujita, Imaizumi, Zoghbi, Fujimura, Farris, Suhara, Hong, Pike, Innis 2008; 40 Imaizumi, Briard, Zoghbi, Gourley, Hong, Musachio, Gladding, Pike, Innis, Fujita 2007; 61 Golani, Weizman, Leschiner, Spanier, Eckstein, Limor, Yanai, Maaser, Scherubl, Weisinger, Gavish 2001; 40 Kurumaji, Nomoto, Yoshikawa, Okubo, Toru 2000; 107 Okubo, Yoshikawa, Chaki, Okuyama, Nakazato 2004; 12 Ramsay, Weiller, Myers, Cremer, Luthra, Lammertsma, Frackowiak 1992; 339 bibr18-jcbfm.2010.63 bibr26-jcbfm.2010.63 bibr8-jcbfm.2010.63 bibr13-jcbfm.2010.63 bibr21-jcbfm.2010.63 bibr29-jcbfm.2010.63 bibr15-jcbfm.2010.63 bibr23-jcbfm.2010.63 bibr6-jcbfm.2010.63 bibr2-jcbfm.2010.63 bibr19-jcbfm.2010.63 bibr10-jcbfm.2010.63 bibr25-jcbfm.2010.63 bibr4-jcbfm.2010.63 bibr12-jcbfm.2010.63 bibr9-jcbfm.2010.63 bibr17-jcbfm.2010.63 bibr27-jcbfm.2010.63 bibr20-jcbfm.2010.63 bibr14-jcbfm.2010.63 bibr1-jcbfm.2010.63 bibr28-jcbfm.2010.63 bibr7-jcbfm.2010.63 bibr16-jcbfm.2010.63 bibr22-jcbfm.2010.63 bibr24-jcbfm.2010.63 bibr11-jcbfm.2010.63 bibr5-jcbfm.2010.63 bibr3-jcbfm.2010.63 bibr30-jcbfm.2010.63 |
References_xml | – volume: 38 start-page: 3843 year: 1989 end-page: 9 article-title: Species differences and heterogeneity of solubilized peripheral-type benzodiazepine binding sites publication-title: Biochem Pharmacol – volume: 32 start-page: 412 year: 2008 end-page: 9 article-title: Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study publication-title: Neurobiol Dis – volume: 61 start-page: 595 year: 2007 end-page: 605 article-title: Kinetic evaluation in nonhuman primates of two new PET ligands for peripheral benzodiazepine receptors in brain publication-title: Synapse – volume: 49 start-page: 2924 year: 2010 end-page: 32 article-title: Comparison of [(11)C]-(R)-PK 11195 and [(11)C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker publication-title: Neuroimage – volume: 340 start-page: 89 year: 1997 end-page: 99 article-title: Characterization of binding sites for the omega3 receptor ligands [3H]PK11195 and [3H]RO5–4864 in human brain publication-title: Eur J Pharmacol – volume: 38 start-page: 19 year: 1998 end-page: 26 article-title: Assessment of the peripheral benzodiazepine receptors in human gliomas by two methods publication-title: J Neurooncol – volume: 39 start-page: 1289 year: 2008 end-page: 98 article-title: Brain and whole-body imaging in nonhuman primates of [11C]PBR28, a promising PET radioligand for peripheral benzodiazepine receptors publication-title: Neuroimage – volume: 518 start-page: 199 year: 1990 end-page: 208 article-title: Peripheral-type benzodiazepine receptors in human glioblastomas: pharmacologic characterization and photoaffinity labeling of ligand recognition site publication-title: Brain Res – volume: 51 start-page: 17 year: 2008 end-page: 30 article-title: Synthesis and evaluation in monkey of two sensitive 11C-labeled aryloxyanilide ligands for imaging brain peripheral benzodiazepine receptors publication-title: in vivo. J Med Chem – volume: 55 start-page: 2048 year: 1990 end-page: 57 article-title: Comparison of the in vitro receptor binding properties of N-[3H]methylspiperone and [3H]raclopride to rat and human brain membranes publication-title: J Neurochem – volume: 137 start-page: 5727 year: 1996 end-page: 30 article-title: Acute action of choriogonadotropin on Leydig tumor cells: changes in the topography of the mitochondrial peripheral-type benzodiazepine receptor publication-title: Endocrinology – volume: 40 start-page: 43 year: 2008 end-page: 52 article-title: Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation publication-title: Neuroimage – volume: 135 start-page: 1576 year: 1994 end-page: 83 article-title: Acute action of choriogonadotropin on Leydig tumor cells: induction of a higher affinity benzodiazepine-binding site related to steroid biosynthesis publication-title: Endocrinology – volume: 27 start-page: 402 year: 2006 end-page: 9 article-title: Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function publication-title: Trends Pharmacol Sci – volume: 67 start-page: 1001 year: 2008 end-page: 10 article-title: The positron emission tomography ligand DAA1106 binds with high affinity to activated microglia in human neurological disorders publication-title: J Neuropathol Exp Neurol – volume: 272 start-page: 28102 year: 1997 end-page: 6 article-title: The Mr 18,000 subunit of the peripheral-type benzodiazepine receptor exhibits both benzodiazepine and isoquinoline carboxamide binding sites in the absence of the voltage-dependent anion channel or of the adenine nucleotide carrier publication-title: J Biol Chem – volume: 53 start-page: 494 year: 1989 end-page: 502 article-title: Differential binding properties of the peripheral-type benzodiazepine ligands [3H]PK 11195 and [3H]Ro 5–4864 in trout and mouse brain membranes publication-title: J Neurochem – volume: 40 start-page: 10213 year: 2001 end-page: 22 article-title: Hormonal regulation of peripheral benzodiazepine receptor binding properties is mediated by subunit interaction publication-title: Biochemistry – volume: 107 start-page: 491 year: 2000 end-page: 500 article-title: An association study between two missense variations of the benzodiazepine receptor (peripheral) gene and schizophrenia in a Japanese sample publication-title: J Neural Transm – volume: 123 start-page: 2321 issue: Part 11 year: 2000 end-page: 37 article-title: The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity publication-title: Brain – volume: 35 start-page: 305 year: 2008 end-page: 14 article-title: Radiosynthesis and initial evaluation of [18F]-FEPPA for PET imaging of peripheral benzodiazepine receptors publication-title: Nucl Med Biol – volume: 284 start-page: 536 year: 2001 end-page: 41 article-title: Structural and functional study of reconstituted peripheral benzodiazepine receptor publication-title: Biochem Biophys Res Commun – volume: 49 start-page: 1407 year: 1987 end-page: 14 article-title: Binding of [3H]Ro 5–4864 and [3H]PK 11195 to cerebral cortex and peripheral tissues of various species: species differences and heterogeneity in peripheral benzodiazepine binding sites publication-title: J Neurochem – volume: 124 start-page: 2014 issue: Part 10 year: 2001 end-page: 27 article-title: In vivo visualization of activated glia by [11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion publication-title: Brain – volume: 21 start-page: 404 year: 2006 end-page: 12 article-title: In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease publication-title: Neurobiol Dis – volume: 51 start-page: 3700 year: 2008 end-page: 12 article-title: Synthesis and biological evaluation of substituted [18F]imidazo[1,2-a]pyridines and [18F]pyrazolo [1,5-a]pyrimidines for the study of the peripheral benzodiazepine receptor using positron emission tomography publication-title: J Med Chem – volume: 339 start-page: 1054 year: 1992 end-page: 5 article-title: Monitoring by PET of macrophage accumulation in brain after ischaemic stroke publication-title: Lancet – volume: 63 start-page: 118 year: 1988 end-page: 21 article-title: Effects of temperature on the in vitro binding of 3H-raclopride to rat striatal dopamine-D2 receptors publication-title: Pharmacol Toxicol – volume: 12 start-page: 423 year: 2004 end-page: 38 article-title: Design, synthesis and structure-affinity relationships of aryloxyanilide derivatives as novel peripheral benzodiazepine receptor ligands publication-title: Bioorg Med Chem – volume: 18 start-page: 49 year: 1987 end-page: 61 article-title: Labelling of peripheral-type benzodiazepine binding sites in human brain with [3H]PK 11195: anatomical and subcellular distribution publication-title: Brain Res Bull – ident: bibr14-jcbfm.2010.63 doi: 10.1016/j.nbd.2005.08.002 – ident: bibr21-jcbfm.2010.63 doi: 10.1016/j.neuroimage.2009.11.056 – ident: bibr13-jcbfm.2010.63 doi: 10.1016/j.neuroimage.2007.11.011 – ident: bibr26-jcbfm.2010.63 doi: 10.1016/j.tips.2006.06.005 – ident: bibr6-jcbfm.2010.63 doi: 10.1021/jm0707370 – ident: bibr9-jcbfm.2010.63 doi: 10.1016/0361-9230(87)90033-5 – ident: bibr19-jcbfm.2010.63 doi: 10.1002/syn.20394 – ident: bibr15-jcbfm.2010.63 doi: 10.1021/bi010431+ – ident: bibr7-jcbfm.2010.63 doi: 10.1016/0006-8993(90)90973-F – ident: bibr4-jcbfm.2010.63 doi: 10.1210/endo.135.4.7925120 – ident: bibr22-jcbfm.2010.63 doi: 10.1007/s007020070090 – ident: bibr11-jcbfm.2010.63 doi: 10.1111/j.1471-4159.1989.tb07361.x – ident: bibr10-jcbfm.2010.63 doi: 10.1016/j.nbd.2008.08.001 – ident: bibr27-jcbfm.2010.63 doi: 10.1016/0140-6736(92)90576-O – ident: bibr2-jcbfm.2010.63 doi: 10.1016/0006-2952(89)90594-7 – ident: bibr28-jcbfm.2010.63 doi: 10.1016/S0014-2999(97)01395-2 – ident: bibr29-jcbfm.2010.63 doi: 10.1097/NEN.0b013e318188b204 – ident: bibr1-jcbfm.2010.63 doi: 10.1111/j.1471-4159.1987.tb01007.x – ident: bibr16-jcbfm.2010.63 doi: 10.1111/j.1471-4159.1990.tb05794.x – ident: bibr30-jcbfm.2010.63 doi: 10.1016/j.nucmedbio.2007.12.009 – ident: bibr23-jcbfm.2010.63 doi: 10.1006/bbrc.2001.4975 – ident: bibr25-jcbfm.2010.63 doi: 10.1016/j.bmc.2003.10.050 – ident: bibr3-jcbfm.2010.63 doi: 10.1093/brain/123.11.2321 – ident: bibr5-jcbfm.2010.63 doi: 10.1210/endo.137.12.8940407 – ident: bibr24-jcbfm.2010.63 doi: 10.1023/A:1005933226966 – ident: bibr8-jcbfm.2010.63 doi: 10.1093/brain/124.10.2014 – ident: bibr20-jcbfm.2010.63 doi: 10.1074/jbc.272.44.28102 – ident: bibr12-jcbfm.2010.63 doi: 10.1021/jm7014556 – ident: bibr17-jcbfm.2010.63 doi: 10.1111/j.1600-0773.1988.tb00922.x – ident: bibr18-jcbfm.2010.63 doi: 10.1016/j.neuroimage.2007.09.063 |
SSID | ssj0008355 |
Score | 2.4204035 |
Snippet | [11C]PBR28, a radioligand targeting the translocator protein (TSPO), does not produce a specific binding signal in approximately 14% of healthy volunteers.... [ 11 C]PBR28, a radioligand targeting the translocator protein (TSPO), does not produce a specific binding signal in approximately 14% of healthy volunteers.... [(11)C]PBR28, a radioligand targeting the translocator protein (TSPO), does not produce a specific binding signal in approximately 14% of healthy volunteers.... [ super(11)C]PBR28, a radioligand targeting the translocator protein (TSPO), does not produce a specific binding signal in approximately 14% of healthy... [ 11 C]PBR28, a radioligand targeting the translocator protein (TSPO), does not produce a specific binding signal in approximately 14% of healthy volunteers.... |
SourceID | pubmedcentral proquest pubmed pascalfrancis crossref sage |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1608 |
SubjectTerms | Acetamides - metabolism Adult Aged Aged, 80 and over Autoradiography Binding Sites Binding, Competitive - drug effects Biological and medical sciences Brain - diagnostic imaging Brain Chemistry Carbon Radioisotopes Female Humans Immunohistochemistry Investigative techniques, diagnostic techniques (general aspects) Isoquinolines Male Medical sciences Membranes - diagnostic imaging Membranes - metabolism Middle Aged Nerve Tissue Proteins - analysis Nerve Tissue Proteins - metabolism Nervous system Neuritis - diagnostic imaging Neurology Original Positron-Emission Tomography Pyridines - metabolism Radioligand Assay Receptors, GABA - metabolism Tissue Banks Ultrasonic investigative techniques Vascular diseases and vascular malformations of the nervous system |
Title | Two Binding Sites for [3H]PBR28 in Human Brain: Implications for TSPO PET Imaging of Neuroinflammation |
URI | https://journals.sagepub.com/doi/full/10.1038/jcbfm.2010.63 https://www.ncbi.nlm.nih.gov/pubmed/20424634 https://www.proquest.com/docview/749402874 https://www.proquest.com/docview/759316211 https://pubmed.ncbi.nlm.nih.gov/PMC2949260 |
Volume | 30 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fa9RAEB60fVCQoq3WWD0WlD659HaT2yS-SFuuHIL1qFc4EAn7K3hik9O7Uvrfd2aTS3tYfUhedhKy2cnuNztfvgF453BVxWVkwHNlS56UQnOd5oJLi_jZZDo2njb0P5-q0XnyaTqYttycRUurXM2JYaJ2taU98oM0yTHUydLk4_w3p6JRlFxtK2g8hE1SLiOnTqddvEXgIjAYZSo4zsnTVmKzH2cHP60pLxpil4rXlqQnc73At1M2ZS3uw51_0yfvcMDCsnTyFLZaPMkOGwd4Bg98tQ07hxXG0hfXbJ8FhmfYOt-GR8er6m47UE6uamZm4Z8WRp1cMISv7Fs8-j4-OpMZm1Us1O9jhopIfGCzO9TzYDr5Ov7CxsMJtoRKR6wuWVDHRJ9FN2t-iXwO5yfDyfGItzUXuE3SZMmd0CS3g-cy16T2lsoSMZX3GKZlfSuVIQSgvcuE8salTlPeM3deGyWt8PEL2Kjqyr8ERmCk73BGcBjyJVpoN9BC4WGlyYzMI3i_eu2FbQXJqS7GryIkxuOsCKNU0CgVKo5gvzOfN0oc_zLsrY1hZ43gMceuiQj2VoNatF_souj8KwLWteKYUP5EV76-RJMBXq4k3WC38YDbW1MGWcV4cbrmG50BqXivt1SzH0HNW-ak2diP4C150e0D3du3V_999D143JAbiAL3GjaWfy79G8RMS9MLX0YPNo-Gp-OzG_a6FqA |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3dT9RAEJ8gPmBijIIfFcFNVJ5saLe9bWtiDCLkkA8vWpJLiKm73W08I-3BHSH8Uf6PzGw_4CL6xkP7srObbWd25zc7szMArzVqVVQjPTcReeGGhS9dGSW-y3PEzyqWgTJ0oL9_IPqH4edhbzgHf9q7MBRW2e6JdqPWVU5n5OtRmKCpE0fhh_GJS0WjyLnaVtCopWLXXJyjxTZ5v_MJ2fuG8-2tdLPvNkUF3DyMwqmrfUn5ZPBdJJLSmUW8QNBgDNohsZdzoUjFSaNjXxilIy3JsZdoI5XguW8CHPcO3MUhPLL1omFn3xGYsRGTPPJd1AHDJqWnF8Trv3JVHNeBZCKYUYH3x3KC3CjqMho34dy_wzWvxZxZNbj9EB40-JVt1AL3COZMuQhLGyXa7scXbI3ZiFJ7VL8IC5ttNbklKNLziqmRvUPD6KdOGMJldhT0vw8-fuUxG5XM1gtkiopWvGOja6HuljT9NvjCBlspttjKSqwqmM3GiWsExbq-gvkYDm-FHU9gvqxK8wwYgR9P4w6k0cQMpS91T_oCn5yrWPHEgbftb8_yJgE61eH4nVlHfBBnlksZcSkTgQNrHfm4zvzxL8LVGR521AhWE_w034HllqlZs0NMsk6eHWBdK_KE_DWyNNUZkvSwu-A0wNNaAq6GJo-1CLBzNCMbHQFlDZ9tKUc_bfZwnlCOSM-BVyRFVxO68due_3fqL2Ghn-7vZXs7B7vLcK8OrKDwuxcwPz09MyuI16Zq1a4SBj9ue1leAi8SUWE |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Two+binding+sites+for+%5B+super%283%29H%5DPBR28+in+human+brain%3A+implications+for+TSPO+PET+imaging+of+neuroinflammation&rft.jtitle=Journal+of+cerebral+blood+flow+and+metabolism&rft.au=Owen%2C+David+R&rft.au=Howell%2C+Owain+W&rft.au=Tang%2C+Sac-Pham&rft.au=Wells%2C+Lisa+A&rft.date=2010-09-01&rft.issn=0271-678X&rft.volume=30&rft.issue=9&rft.spage=1608&rft.epage=1618&rft_id=info:doi/10.1038%2Fjcbfm.2010.63&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0271-678X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0271-678X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0271-678X&client=summon |